Page 19 - The DHEA Debate - Life Extensions Magazine

16. Baulieu EE. Dehydroepiandrosterone (DHEA): a fountain of youth? J Clin Endocrinol Metab.
1996 Sep;81(9):3147- 51.
17. van Broekhoven F, Verkes RJ. Neurosteroids in depression: a review.
Psychopharmacology. (Berl). 2003 Jan;165(2):97-110. Epub 2002 Nov 06.
18. Nadjafi-Triebsch C, Huell M, Burki D, Rohr UD. Progesterone increase under DHEA-
substitution in males. Maturitas. 2003 Jul 25;45(3):231-5.
19. Arlt W, Callies F, Allolio B. DHEA replacement in women with adrenal insufficiency—
pharmacokinetics, bioconversion and clinical effects on well-being, sexuality and cognition.
Endocr Res. 2000 Nov;26(4):505-11.

20. Wolkowitz OM, Reus VI, Roberts E, et al. Antidepressant and cognition-enhancing effects of
DHEA in major depression. Ann NY Acad Sci. 1995 Dec 29;774:337-9.
21. Bloch M, Schmidt PJ, Danaceau MA, Adams LF, Rubinow DR. Dehydroepiandrosterone
treatment of midlife dysthymia. Biological Psychiatry. 1999 Jun 15;45(12):1533-41.
22. Jesse RL, Loesser K, Eich DM, Qian YZ, Hess ML, Nestler JE. Dehydroepiandrosterone
inhibits human platelet aggregation in vitro and in vivo. Ann NY Acad Sci. 1995 Dec 29;774:281-
90.

23. Barret-Connor E, Knaw KT, Yen SSC. A prospective study of dehydroepiandrosterone
sulfate, mortality and cardiovascular disease. N Engl J Med. 1986 Dec 11; 315:1519-24.

24. Shono N, Kumagai S, Higaki Y, Nishizumi M, Sasaki H. The relationships of testosterone,
estradiol, dehydroepiandrosterone-sulfate and sex hormone-binding globulin to lipid and
glucose metabolism in healthy men. J Atherosclerosis and Thrombosis. 1996;3(1):45-51.

25. Okamoto K. Relationship between dehydroepiandrosterone sulfate and serum lipid levels in
Japanese men. J Epidemiol. 1996 Jun;6(2):63-7.

26. Tagawa N, Tamanaka J, Fujinami A, et al. Serum dehydroepiandrosterone, dehy-
droepiandosterone sulfate, and pregnenolone sulfate concentrations in patients with
hyperthyroidism and hypothyroidism. Clin Chem. 2000 Apr; 46(4):523-528.
27. Inaudi P, Massafra C, Bernabei A, Antoni G, D’Antona N. Gonadotropin, prolactin and
thyrotropin pituitary secretion after exogenous dehydroepiandrosterone sulfate administration in
normal women. Horm Red. 1991;35(1):35-40.
28. Tagawa N, Tokano T, Fukata S, et al. Serum concentrations of androstenediol and
androstenediol sulfate in patients with hyperthyroidism and hypothyroidism. Endocr J.
2001;48:345-54.

29. Vranckx R, Mechighel P, Savu L. Effect of dehydroepiandrosterone on rat thyroxine binding
globulin, a protein upregulated during aging. Ann NY Acad Sci. 1995 Dec 29; 774:335-6.

30. Bickova M, Tallova J, Hill M, Vanuga A, Putz Z, Tomandl J. Effect of treatment of
hypothyroidism on the plasma concentra- tions of neuroactive steroids and homocysteine. Clin
Chem Lab Med. 2001; 39:753-7.

31. de Bruin VM, Vieira MC, Rocha MN, Viana GS. Cortisol and dehydroepiandosterone sulfate
plasma levels and their relationship to aging, cognitive function, and dementia. Brain Cogn.
2002 Nov;50(2):316-23.